Exchange transfusions in severe Rh‐mediated alloimmune haemolytic disease of the foetus and newborn: a 20‐year overview on the incidence, associated risks and outcome-Reference-Cited by-同舟云学术

Exchange transfusions in severe Rh‐mediated alloimmune haemolytic disease of the foetus and newborn: a 20‐year overview on the incidence, associated risks and outcome

Published:2021-03-17 Issue:9 Volume:116 Page:990-997
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Ree Isabelle M. C.¹²^ORCID,Besuden Carolin F. J.¹,Wintjens Vivianne E. H. J.¹,Verweij Joanne (E.) J. T.³,Oepkes Dick³,Haas Masja²⁴⁵,Lopriore Enrico¹

Affiliation:

1. Department of Paediatrics Division of Neonatology Leiden University Medical Centre Leiden the Netherlands

2. Centre for Clinical Transfusion Research Sanquin Leiden the Netherlands

3. Department of Obstetrics Division of Foetal Medicine Leiden University Medical Centre Leiden the Netherlands

4. Department of Immunohaematology and Blood Transfusion Leiden University Medical Centre Leiden the Netherlands

5. Department of Immunohematology Diagnostics Sanquin Amsterdam the Netherlands

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vox.13090

Reference26 articles.

1. Neonatal management and outcome in alloimmune hemolytic disease

2. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation

3. Late hyporegenerative anemia in neonates with rhesus hemolytic disease

4. Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome

5. Blood Exchange Transfusion for Infants with Severe Neonatal Hyperbilirubinemia

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use and Waste of Reconstituted Whole Blood Exchange Transfusions: An 11-year National Observational Study;The Journal of Pediatrics;2024-12

2. Kommentar;Transfusionsmedizin;2024-05

3. Erythrokinetic mechanism(s) causing the “late anemia” of hemolytic disease of the fetus and newborn;Journal of Perinatology;2024-01-12

4. Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial;The Lancet Haematology;2023-12

5. Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes;BMC Pregnancy and Childbirth;2023-10-18